Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Editorials
Residual Problems With Repaired Tetralogy of Fallot
Atsushi MizunoKoichiro Niwa
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML

2014 Volume 78 Issue 8 Pages 1837-1838

Details

Tetralogy of Fallot (TOF) includes 4 major anatomical features: right ventricular outflow tract (RVOT) obstruction (hypoplasia); ventricular septal defect; deviation of the origin of the aorta to the right ventricle; and concentric right ventriclular (RV) hypertrophy. TOF is the most common cyanotic congenital heart disease, accounting for 10% of congenital heart disease.1 Despite improved mortality rates of TOF patients, thanks to recent progress in comprehensive management, including intracardiac repair, there are postoperative late complications.2,3 Prevention and management of these are of paramount importance. Sudden death in adulthood is commonly from either ventricular arrhythmia or heart failure. There are operable and non-operable residua and sequelae in adult TOF patients long-term after repair (Figure). It is recognized that patients with RV dilatation and dysfunction with or without severe tricuspid regurgitation have a worse outcome.1,2 The predominant residual lesions responsible for poor prognosis are pulmonary regurgitation and RVOT stenosis.2

Figure.

Simple schematic of the management of repaired tetralogy of Fallot patients. Operable and nonoperable problems need to be managed to prevent late complications. AR, aortic regurgitation; IE, infectious endocarditis; LV left ventricle; PR, pulmonary regurgitation; RV right ventricle; RVOT, right ventricular outflow tract; TR, tricuspid regurgitation; VSD, ventricular septal defect.

Article p 1960

Operable Problems

Pulmonary regurgitation and RVOT stenosis are anatomical complications that can be relieved only by anatomical repair including surgery and percutaneous catheter treatment.4,5 Therefore, appropriate timing of such intervention is important. However, definite criteria for reoperation are not yet determined. There were several advocated criteria for re-intervention using magnetic resonance imaging (MRI).6,7 We routinely decide the timing of reoperation according to the following parameters: RV and LV end-diastolic volume index; RV end-systolic volume index; RV and LV ejection fractions; RVOT aneurysm; exercise intolerance; and presence of heart failure symptoms, syncope, sustained ventricular tachycardia (VT).

Without reoperation, repaired TOF patients with severe anatomical residua and sequelae will develop irreversible RV myocardial damage and heart failure, but there is not conclusive evidence that reoperation for pulmonary regurgitation improves survival.

In Japan, there is also no cut-off value of RV volume or RV ejection fraction or other parameters about the timing of re-operation. MRI was used to assess the timing of re-operation in only 60% of repaired TOF patients in a Japanese multicenter survey.2 Compared with Western countries, the most common reason for re-operation in Japan is RVOT stenosis. Conotruncal repair with the application of small RV outflow patching has been used for the primary repair of TOF.8 This technique may protect against the development of severe pulmonary regurgitation after repair, which results in a lower incidence of huge RV dilatation, RV dysfunction, sustained VT and sudden death than in previous reports from North America and Europe.6,9 In turn, our pre-re-intervention assessment might be reasonable for detecting RVOT stenosis rather than pulmonary regurgitation only by echocardiography. Because there is no consensus about the appropriate timing and also relative merits of preoperative imaging modalities in repaired TOF, we should discuss these residual clinical problems and late complications.

Nonoperable Problems

There are many prognostic variables to predict the long-term outcome of repaired TOF patients, such as RV and LV function, dilatation, inducible VT and cardiopulmonary exercise test results.10,11 These variables are used to predict sudden death from significant arrhythmias. One of the most popular variables used to predict long term outcome is QRS interval, which correlates with RV end-diastolic volume estimated by MRI.12,13 In order to prevent these fatal arrhythmias, the indication for implantable cardiac defibrillator implantation should be guided by several important variables: prior palliative shunt, inducible VT, QRS interval, ventriculotomy, nonsustained VT, and LV end-diastolic pressure.14 Longitudinal LV function also seems to be an important variable in repaired TOF patients to predict a composite endpoint of sudden cardiac death/life-threatening ventricular arrhythmias.15 In this issue of the Journal, Nakamura et al reveal that longitudinal LV dysfunction in repaired TOF is associated with RV dilatation,16 which is also a prognostic variable as mentioned. In Japan, MRI is less commonly used to assess ventricular function than echocardiography. Left longitudinal strain measurement could give additional prognostic information in real-world Japanese clinical practice.

Disclosures

Financial Disclosures and Conflicts of Interest: None.

References
  • 1.    Pandya B, Quail MA, Cullen S. Clinical issues and outcomes in adults following repair of tetralogy of fallot. Curr Treat Options Cardiovasc Med 2013; 15: 602–614.
  • 2.    Mizuno A, Niwa K, Matsuo K, Kawada M, Miyazaki A, Mori Y, et al. Survey of reoperation indications in tetralogy of Fallot in Japan. Circ J 2013; 77: 2942–2947.
  • 3.    Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med 1993; 329: 593–599.
  • 4.    Lindsey CW, Parks WJ, Kogon BE, Sallee D 3rd, Mahle WT. Pulmonary valve replacement after tetralogy of Fallot repair in preadolescent patients. Ann Thorac Surg 2010; 89: 147–151.
  • 5.    Eicken A, Ewert P, Hager A, Peters B, Fratz S, Kuehne T, et al. Percutaneous pulmonary valve implantation: Two-centre experience with more than 100 patients. Eur Heart J 2011; 32: 1260–1265.
  • 6.    Geva T. Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006; 11–22.
  • 7.    Holmes KW. Timing of pulmonary valve replacement in tetralogy of fallot using cardiac magnetic resonance imaging: An evolving process. J Am Coll Cardiol 2012; 60: 1015–1017.
  • 8.    Kurosawa H, Imai Y, Nakazawa M, Momma K, Takao A. Conotruncal repair of tetralogy of Fallot. Ann Thorac Surg 1988; 45: 661–666.
  • 9.    Tirilomis T, Friedrich M, Zenker D, Seipelt RG, Schoendube FA, Ruschewski W. Indications for reoperation late after correction of tetralogy of Fallot. Cardiol Young 2010; 20: 396–401.
  • 10.    Khairy P, Landzberg MJ, Gatzoulis MA, Lucron H, Lambert J, Marcon F, et al. Value of programmed ventricular stimulation after tetralogy of fallot repair: A multicenter study. Circulation 2004; 109: 1994–2000.
  • 11.    Giardini A, Specchia S, Tacy TA, Coutsoumbas G, Gargiulo G, Donti A, et al. Usefulness of cardiopulmonary exercise to predict long-term prognosis in adults with repaired tetralogy of Fallot. Am J Cardiol 2007; 99: 1462–1467.
  • 12.    Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, et al. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of fallot: A multicentre study. Lancet 2000; 356: 975–981.
  • 13.    Knauth AL, Gauvreau K, Powell AJ, Landzberg MJ, Walsh EP, Lock JE, et al. Ventricular size and function assessed by cardiac mri predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart 2008; 94: 211–216.
  • 14.    Khairy P, Harris L, Landzberg MJ, Viswanathan S, Barlow A, Gatzoulis MA, et al. Implantable cardioverter-defibrillators in tetralogy of fallot. Circulation 2008; 117: 363–370.
  • 15.    Diller GP, Kempny A, Liodakis E, Alonso-Gonzalez R, Inuzuka R, Uebing A, et al. Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of Fallot. Circulation 2012; 125: 2440–2446.
  • 16.    Nakamura A, Horigome H, Seo Y, Ishizu T, Sumazaki R. Right ventricular remodeling due to pulmonary regurgitation is associated with reduced left ventricular free wall strain in surgically repaired tetralogy of Fallot. Circ J 2014; 78: 1960–1966.
 
© 2014 2013 THE JAPANESE CIRCULATION SOCIETY
feedback
Top